PATRICK G. ENRIGHT - 10 Feb 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Director, 10%+ Owner
Signature
/s/ Patrick G. Enright
Issuer symbol
VERA
Transactions as of
10 Feb 2022
Net transactions value
+$4,999,995
Form type
4
Filing time
05 Apr 2022, 07:22:45 UTC
Previous filing
20 Aug 2021
Next filing
26 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Purchase $4,999,995 +333,333 +11% $15.00 3,429,927 10 Feb 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Remarks:

This Form 4 is being filed late due to an administrative error.